01 3Eperzan/Tanzeum
Main Therapeutic Indication : Diabetes
Currency : USD
2016 Revenue in Millions : 150
2015 Revenue in Millions : 50
Growth (%) : 200
Main Therapeutic Indication : Diabetes
Currency : USD
2017 Revenue in Millions : 123
2016 Revenue in Millions : 171
Growth (%) : -28
Main Therapeutic Indication : Diabetes
Currency : USD
2018 Revenue in Millions : 41
2017 Revenue in Millions : 116
Growth (%) : -64%
LOOKING FOR A SUPPLIER?